Observational Study of Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
N/A
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Urothelial Carcinoma
Both
Urothelial Carcinoma
Trial Information
Observational Study of Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
Inclusion Criteria:
- the resected kidney tissue in the tissue bank
Exclusion Criteria:
- the patients who had been ever exposed to arsenics, rubber, chemicals, irradiation
for pelvis, or received chemotherapy.
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Cross-Sectional
Outcome Measure:
the incidence of aristolochic-acid DNA adduct in the samples
Outcome Time Frame:
one week
Safety Issue:
No
Authority:
Taiwan: Department of Health
Study ID:
200804011R
NCT ID:
NCT00867633
Start Date:
March 2009
Completion Date:
March 2012
Related Keywords:
- Urothelial Carcinoma
- urothelial carinoma
- aristolochic acid
- DNA
- adduct
- Carcinoma
- Carcinoma, Transitional Cell
Name | Location |
|---|
